ERBB2 and breast carcinoma: As one example, in patients with HER2-positive early-stage breast cancer, neoadjuvant anti-HER2 therapy plus chemotherapy followed by surgery and adjuvant therapy with anti-HER2 therapy was beneficial only for patients without a pCR (133).